Le Lézard
Classified in: Health, Business
Subjects: PER, CXP

Atlanta Fibroid Center Announces Expansion


ATLANTA, Jan. 17, 2019 /PRNewswire/ -- Dr. John Lipman, founder and medical director of Atlanta Fibroid Center of Atlanta Interventional Institute, welcomes his new colleague, Dr. Rochelle Wolfe, as the company expands beyond its headquarters in Smyrna, GA. Dr. Wolfe is a board-certified radiologist with fellowship training and extensive interventional radiology experience.

"We are extraordinarily pleased to welcome Dr. Wolfe as an integral part of our growing medical team," said Dr. Lipman, an interventional radiologist and internationally-recognized expert in the uterine fibroid embolization (UFE) procedure.

Dr. Wolfe Brings Expertise in UFE as well as Venous Disease
After completing medical school at the University of Minnesota, Dr. Wolfe completed her radiology residency at Brown University School of Medicine in Providence, RI. She pursued an interventional radiology fellowship at the University of California, San Diego, where she was fortunate to work with a pioneer in UFE, well-known interventional radiologist, Dr. Ann C. Roberts

Dr. Wolfe was one of the first physicians in Minnesota to perform the UFE procedure through the wrist and has comprehensive experience treating patients with venous disease.

UFE Provides a Non-Invasive Option for the Treatment of Uterine Fibroids
Uterine Fibroid Embolization is an outpatient non-surgical option for treating symptomatic uterine fibroids. Fibroids are the most common pelvic tumor encountered by women, and are found in up to 80% of African-American women. Following the UFE procedure, patients recuperate within the comfort of their own homes on the same day of the procedure. Typically, a woman requires less than a week to fully recover from UFE. More invasive surgical procedures, such as hysterectomy and myomectomy, often require two months or more for complete recovery.

While the company's headquarters in Smyrna will still house its state-of-the-art UFE procedure suite, its two new offices will be conveniently located for patient consultations in mid-town Atlanta and Lithonia.

Founded in 2005, Atlanta Fibroid Center of Atlanta Interventional Institute is a global leader in UFE with over 8,000 UFE procedures completed by its physicians. Dr. Wolfe and Dr. Lipman are available for appointments by calling 770-953-2600, or requesting an appointment on the company website, https://ATLii.com.

For more information on Product:
                https://ATLii.com
                http://DrJohnLipman.com
                http://DrRochelleWolfe.com

An image of Dr. Wolfe is available for download at:
                http://bit.ly/2RPXMX1

SOURCE Atlanta Fibroid Center of Atlanta Interventional Institute


These press releases may also interest you

at 01:15
The first-ever public auction of the epic satoshi held by CoinEx, the leading global cryptocurrency exchange, ended on April 25, 2024, at 16:00 (UTC). As the first example shown in history, the auction attracted global users for 35 bids, and the epic...

25 avr 2024
AZZ Inc. , the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the pricing of its underwritten public offering of 4,000,000 shares of common stock at a public offering price per share of $70.00, for...

25 avr 2024
CarLotz, Inc.  Accused of Misleading Investors On March 29, 2024, the defendants' motion to dismiss in the pending securities class...

25 avr 2024
TSX VENTURE COMPANIES BULLETIN V2024-1200 LEONOVUS INC. ("LTV.WT")BULLETIN TYPE:  Warrant Expiry-DelistBULLETIN DATE:  April 25, 2024TSX Venture Tier 2 Company Effective at the opening, May 2, 2024, the Share Purchase Warrants of the Company will...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
Dominion Lending Centres Inc. ("DLCG" or the "Corporation") is pleased to announce that it has completed a sale of its 52% interest in Cape Communications International Inc. ("Impact") for aggregate cash proceeds of $3.71 million (the "Purchase...



News published on and distributed by: